Study of acceptability, efficacy and side effects of non-steroidal contraceptive ormeloxifene and its comparative evaluation with combined oral contraceptives

Background: Despite their efficacy, COCs are associated with various side effects, including mood changes, weight gain, and cardiovascular risks, which can limit their acceptability among some women. These challenges have prompted ongoing research into alternative contraceptive methods that offer effective pregnancy prevention while mitigating hormonal side effects. In this context we conducted a study to assess the acceptability, effectiveness, and side effects of the non-steroidal contraceptive ormeloxifene for contraception, and to compare it with combined oral contraceptives (COCs). Methods: The study was a prospective longitudinal study carried out in the department of obstetrics and gynecology (UISEMH), GSVM medical college, Kanpur, Uttar Pradesh, India. Results: The study included two groups: 90 women opted for ormeloxifene (postpartum, post-abortal, and interval cases) as their contraceptive method, while another 53 women chose combined oral contraceptives (post-abortal and interval cases). The majority of participants in both groups were aged between 26 and 30 years. Patients were monitored for one year, with assessments conducted at the 3rd, 6th, and 12th months following initiation of the oral pills, and no participants were lost to follow-up. The study found statistically significant differences, particularly noting an 85.5% continuation rate with ormeloxifene, which was markedly higher compared to 39.6% observed with COCs. Conclusions: Ormeloxifene is a safe non-steroidal contraceptive option for pregnancy spacing and demonstrates comparable acceptability to COCs. Side effects beyond menstrual issues (such as weight gain, nausea, vomiting, and headache) are the primary reasons for discontinuation of COCs. Both hormonal (combined oral contraceptives) and non-hormonal (ormeloxifene) oral contraceptive pills are safe and effective methods of contraception.

Authors

Institutions

Publication Details

Journal
International Journal of Reproduction Contraception Obstetrics and Gynecology
Published
2024-11-28
DOI
https://doi.org/10.18203/2320-1770.ijrcog20243590
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of acceptability, efficacy and side effects of non-steroidal contraceptive ormeloxifene and its comparative evaluation with combined oral contraceptives

Divya Dwivedi, Emad Siddiqui, Neena Gupta, Uruj Jahan
International Journal of Reproduction Contraception Obstetrics and Gynecology
Reproductive Health and Contraception
article

Study of acceptability, efficacy and side effects of non-steroidal contraceptive ormeloxifene and its comparative evaluation with combined oral contraceptives

Divya Dwivedi, Emad Siddiqui, Neena Gupta, Uruj Jahan
article en

Abstract

Background: Despite their efficacy, COCs are associated with various side effects, including mood changes, weight gain, and cardiovascular risks, which can limit their acceptability among some women. These challenges have prompted ongoing research into alternative contraceptive methods that offer effective pregnancy prevention while mitigating hormonal side effects. In this context we conducted a study to assess the acceptability, effectiveness, and side effects of the non-steroidal contraceptive ormeloxifene for contraception, and to compare it with combined oral contraceptives (COCs). Methods: The study was a prospective longitudinal study carried out in the department of obstetrics and gynecology (UISEMH), GSVM medical college, Kanpur, Uttar Pradesh, India. Results: The study included two groups: 90 women opted for ormeloxifene (postpartum, post-abortal, and interval cases) as their contraceptive method, while another 53 women chose combined oral contraceptives (post-abortal and interval cases). The majority of participants in both groups were aged between 26 and 30 years. Patients were monitored for one year, with assessments conducted at the 3rd, 6th, and 12th months following initiation of the oral pills, and no participants were lost to follow-up. The study found statistically significant differences, particularly noting an 85.5% continuation rate with ormeloxifene, which was markedly higher compared to 39.6% observed with COCs. Conclusions: Ormeloxifene is a safe non-steroidal contraceptive option for pregnancy spacing and demonstrates comparable acceptability to COCs. Side effects beyond menstrual issues (such as weight gain, nausea, vomiting, and headache) are the primary reasons for discontinuation of COCs. Both hormonal (combined oral contraceptives) and non-hormonal (ormeloxifene) oral contraceptive pills are safe and effective methods of contraception.

International Journal of Reproduction Contraception Obstetrics and GynecologyVol. 13(12)
Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN), Ganesh Shankar Vidyarthi Memorial Medical College (IN)
Good health and well-being
Openalex Percentile: Top 67%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.